| Authors: |
Bakht MK; Department of Chemistry and Biochemistry, University of Windsor, Windsor, ON N9B 3P4, Canada.; Department of Biomedical Sciences, University of Windsor, Windsor, ON N9B 3P4, Canada.; Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul 03080, Korea.; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215.; Department of Medicine, Harvard Medical School, Boston, MA 02115.; Broad Institute of MIT and Harvard, Cambridge, MA 02142., Hayward JJ; Department of Chemistry and Biochemistry, University of Windsor, Windsor, ON N9B 3P4, Canada., Shahbazi-Raz F; Department of Chemistry and Biochemistry, University of Windsor, Windsor, ON N9B 3P4, Canada., Skubal M; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065., Tamura R; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065., Stringer KF; Department of Biomedical Sciences, University of Windsor, Windsor, ON N9B 3P4, Canada.; Department of Pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229., Meister D; Department of Chemistry and Biochemistry, University of Windsor, Windsor, ON N9B 3P4, Canada., Venkadakrishnan VB; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215.; Department of Medicine, Harvard Medical School, Boston, MA 02115.; Broad Institute of MIT and Harvard, Cambridge, MA 02142., Xue H; Vancouver Prostate Centre, University of British Columbia, Vancouver, BC V6H 3Z6, Canada., Pillon A; Department of Biomedical Sciences, University of Windsor, Windsor, ON N9B 3P4, Canada., Stover M; Department of Biomedical Sciences, University of Windsor, Windsor, ON N9B 3P4, Canada., Tronchin A; Department of Biomedical Sciences, University of Windsor, Windsor, ON N9B 3P4, Canada., Fifield BA; Department of Biomedical Sciences, University of Windsor, Windsor, ON N9B 3P4, Canada., Mader L; Department of Chemistry and Biochemistry, University of Windsor, Windsor, ON N9B 3P4, Canada., Ku SY; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215.; Department of Medicine, Harvard Medical School, Boston, MA 02115., Cheon GJ; Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul 03080, Korea.; Cancer Research Institute, Seoul National University, Seoul 03080, Korea., Kang KW; Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul 03080, Korea.; Cancer Research Institute, Seoul National University, Seoul 03080, Korea., Wang Y; Vancouver Prostate Centre, University of British Columbia, Vancouver, BC V6H 3Z6, Canada., Dong X; Vancouver Prostate Centre, University of British Columbia, Vancouver, BC V6H 3Z6, Canada., Beltran H; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215.; Department of Medicine, Harvard Medical School, Boston, MA 02115.; Broad Institute of MIT and Harvard, Cambridge, MA 02142., Grimm J; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065.; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065.; Pharmacology Program, Weill Cornell Medical College, New York, NY 10065., Porter LA; Department of Biomedical Sciences, University of Windsor, Windsor, ON N9B 3P4, Canada; lporter@uwindsor.ca j.trant@uwindsor.ca., Trant JF; Department of Chemistry and Biochemistry, University of Windsor, Windsor, ON N9B 3P4, Canada; lporter@uwindsor.ca j.trant@uwindsor.ca. |
